TILRAY BRANDS, INC.

(TLRY)
  Report
Delayed Nasdaq  -  05/26 04:00:01 pm EDT
4.660 USD   +5.43%
07:43aTilray Brands Expands UK Portfolio With Launch of CBD Lifestyle Brand Pollen on Amazon UK
MT
07:40aTilray Launches CBD Lifestyle Brand, Pollen, on Amazon UK; Innovative, Delicious CBD Designed to Make You Feel Your Kind of Good
AQ
07:11aTILRAY BRANDS BRIEF : Launches CBD Lifestyle Brand, Pollen, on Amazon UK
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: May 2021 2022 2023 2024
Capitalization1 7 4582 200--
Enterprise Value (EV)1 7 9082 7952 7912 766
P/E ratio -13,3x-111x-19,0x-31,0x
Yield ----
Capitalization / Revenue 14,5x3,47x3,09x2,57x
EV / Revenue 15,4x4,41x3,93x3,23x
EV / EBITDA 194x56,7x32,5x21,0x
Price to Book ----
Nbr of stocks (in thousands) 447 371497 708--
Reference price (USD) 16,74,424,424,42
Announcement Date 07/28/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: May 2019 2020 2021 2022 2023 2024
Net sales1 180407513634711856
EBITDA1 -21,012,940,849,385,8132
Operating profit (EBIT)1 -110-49,4-132-170-102-44,2
Operating Margin -61,2%-12,2%-25,8%-26,8%-14,4%-5,16%
Pre-Tax Profit (EBT)1 -11,8-60,4-345-17,7-116-59,3
Net income1 -12,5-63,3-336-17,8-114-59,9
Net margin -6,96%-15,6%-65,5%-2,81%-16,0%-7,00%
EPS2 ---1,25-0,04-0,23-0,14
Dividend per Share ------
Announcement Date 08/01/201907/29/202007/28/2021---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: May 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales1 168155152156162169
EBITDA1 12,713,810,112,715,818,5
Operating profit (EBIT)1 -36,1-32,0-36,3-29,9-25,0-22,6
Operating Margin -21,5%-20,6%-23,9%-19,2%-15,5%-13,3%
Pre-Tax Profit (EBT)1 -29,80,1350,6-38,5-33,5-31,0
Net income1 -34,6-0,2043,2-39,0-33,7-31,3
Net margin -20,6%-0,13%28,4%-25,1%-20,9%-18,5%
EPS2 -0,08-0,09-0,08-0,07-0,07
Dividend per Share ------
Announcement Date 10/07/202101/10/202204/06/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: May 2019 2020 2021 2022 2023 2024
Net Debt1 --450596591566
Net Cash position1 62,466,1----
Leverage (Debt / EBITDA) 2,97x-5,13x11,0x12,1x6,89x4,30x
Free Cash Flow1 -198-199-83,6-12110,543,0
ROE (Net Profit / Equities) -1,15%-4,81%-11,8%-1,75%-2,40%-1,65%
Shareholders' equity1 1 0861 3172 8541 0184 7433 631
ROA (Net Profit / Asset) --2,96%-8,66%0,20%-1,00%-0,20%
Assets1 -2 1403 882-8 90811 38429 952
Book Value Per Share ------
Cash Flow per Share2 ---0,17-0,030,100,24
Capex1 15699,138,928,627,729,9
Capex / Sales 86,9%24,4%7,58%4,51%3,89%3,50%
Announcement Date 08/01/201907/29/202007/28/2021---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Key data
Capitalization (USD) 2 199 871 410
Net sales (USD) 513 085 000
Number of employees 1 700
Sales / Employee (USD) 301 815
Free-Float 96,1%
Free-Float capitalization (USD) 2 112 992 741
Avg. Exchange 20 sessions (USD) 117 882 032
Average Daily Capital Traded 5,36%
EPS & Dividend
Change in Enterprise Value/EBITDA